Stock TELO TELO GENOMICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Telo Genomics Corp.

Equities

TELO

CA87975M2085

Market Closed - Toronto S.E.
Other stock markets
 15:57:14 2024-04-26 EDT 		5-day change 1st Jan Change
0.17 CAD -5.56% Intraday chart for Telo Genomics Corp. 0.00% -15.00%
04-10 Telo Genomics Receives Accreditation from College of American Pathologists MT
04-10 Telo Genomics Corp. Receives Accreditation from College of American Pathologists CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telo Genomics Receives Accreditation from College of American Pathologists
MT
Telo Genomics Receives Accreditation from College of American Pathologists
NE
Telo Genomics Corp. Receives Accreditation from College of American Pathologists
CI
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%
MT
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial
NE
Telo Genomics Corp. Announces Patient Recruitment for Its Minimal Respiratory Disease Clinical Trial Has Been Initiated, with Several Patient Samples Received and Processed to Date
CI
Telo Genomics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Telo Genomics Corp. Initiates MRD Clinical Trial for Multiple Myeloma Patients
CI
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients
NE
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US
NE
Telo Genomics Corp. Announces Executive Changes
CI
Telo Genomics Gears up for American Society of Hematology Conference
NE
Telo Genomics Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Telo Genomics Launches Physician Experience Program in the United States
NE
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists
NE
Telo Genomics Corp. Announces the American Society of Hematology Accepts the Results of Teloview-Smm Technical Repeatability Validation for Presentation At Their Annual Meeting in December 10, 2023
CI
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting
NE
Telo Genomics Corp. Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Telo Genomics : Consolidated Financial Statements
PU
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TELO Stock
  4. News Telo Genomics Corp.